ORIC logo
ORIC Pharmaceuticals, Inc.(ORIC)
Last print unknown agoAbout this dataData status
$12.72▲0.37 (3.00%)Stale · unknown old

ORIC R&D Expense Growth

-3.73%Fiscal year

Period ending:

ORIC FY R&D Growth (YoY)%
ORIC FY R&D Growth (YoY)186.69%-27.12%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

ORIC r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Oric Pharmaceuticals Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-3.7292%
33.9313%
38.0869%
8.4808%
-6.4281%
165.9954%
20.0673%
-0.5228%
0%

Compare r&d expense growth

All ORIC financial metrics · ORIC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.